HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].

Abstract
In this study, we evaluated the clinical efficacy of cefpodoxime proxetil (CPDX-PR) in otorhinolaryngological infections. The subjects were 205 patients (85 men and 120 women) with various otorhinolaryngological infections, aged from 16 to 81 years (mean 49.2 years): 113 patients had acute infections, 25 patients had chronic infections and 67 patients had acute exacerbation of chronic infections. 1. Clinical evaluation The overall efficacy rate was 75.6%. When classified by disease, the efficacy rate was 84.9%, 60.0%, 65.6% in acute infections, chronic infections and acute exacerbation of chronic infections, respectively. 2. Bacteriological evaluation Frequencies of isolation of different organisms were studied: 49 strains of Staphylococcus aureus, 27 strains of Staphylococcus sp. and 15 strains of Streptococcus sp. were found in the decreasing order of frequencies. Antibacterial activities against S. aureus, Staphylococcus sp. and several other organisms were compared among CPDX-PR, ampicillin, cefaclor, cefteram and norfloxacin: CPDX-PR showed the highest activity. 3. Side effect Mild urticaria was observed in only 1 patient. Abnormal laboratory test results were mild elevation of GOT and GPT in 3 of 43 patients. Based on the above results, we consider that CPDX-PR is useful for treatment of otorhinolaryngological infections.
AuthorsH Takeuchi, H Ikoma, T Suzuki, M Nakajima, Y Kouzaki, Y Ishizu, H Makino, S Sugihara, S Ootawara, K Asagi
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 47 Issue 1 Pg. 84-92 (Jan 1994) ISSN: 0368-2781 [Print] Japan
PMID8114275 (Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Prodrugs
  • cefpodoxime proxetil
  • Ceftizoxime
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bacteria (drug effects, isolation & purification)
  • Bacterial Infections (drug therapy, microbiology)
  • Ceftizoxime (analogs & derivatives, pharmacology, therapeutic use)
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Otorhinolaryngologic Diseases (drug therapy, microbiology)
  • Prodrugs (pharmacology, therapeutic use)
  • Staphylococcal Infections (drug therapy)
  • Streptococcal Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: